We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
SynapDx Corporation, Broad Institute Collaborate on NGS Analytics for Diagnostic Applications
News

SynapDx Corporation, Broad Institute Collaborate on NGS Analytics for Diagnostic Applications

SynapDx Corporation, Broad Institute Collaborate on NGS Analytics for Diagnostic Applications
News

SynapDx Corporation, Broad Institute Collaborate on NGS Analytics for Diagnostic Applications

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "SynapDx Corporation, Broad Institute Collaborate on NGS Analytics for Diagnostic Applications"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

SynapDx Corporation today announced that it has formed a collaboration with the Broad Institute of Harvard and MIT. The collaboration brings together scientists with leading expertise in computational biology and software engineering to accelerate advances in next generation sequencing. 

SynapDx is currently conducting one of the largest prospective, multi-center studies to analyze blood from children undergoing clinical evaluation for autism spectrum disorder (ASD). The objective of the collaboration is to develop advanced next generation sequencing (NGS) analysis techniques to further enhance test accuracy and clinical utility in autism diagnostics.  

"We are thrilled to be working with SynapDx.  Our collaboration will enable us to really push the methods for variant detection in new directions," said Eric Banks, Group Leader of Genome Sequencing and Analysis at the Broad Institute.

“Our partnership with the Broad  Institute  helps advance  our  mission  by  developing  powerful tools for the analysis of  next generation sequencing  data  that  will  have broad application in  the  detection of  autism and beyond ,”  said  Mark DePristo, SynapDx Vice President of  Informatics .

Advertisement